| Sung Wan Kim | |
| Death Place: | Salt Lake City, Utah, U.S. |
| Birth Date: | August 21, 1940 |
| Death Date: | February 24, 2020 (aged 79) |
| Birth Place: | Pusan, South Korea |
| Education: | Seoul National University (BS, MS) University of Utah (PhD) |
| Workplaces: | University of Utah |
| Discipline: | Medicinal chemistry Pharmacology |
| Sub Discipline: | Pharmaceutics Drug delivery |
Sung Wan Kim (August 21, 1940 – February 24, 2020) was a South Korean-American academic who worked as a distinguished professor of pharmaceutics and pharmaceutical chemistry at the University of Utah. He is the founder and co-director of the University of Utah's Center for Controlled Chemical Delivery.
Kim was born in Pusan, South Korea. He received his B.S. and M.S. at Seoul National University in 1963 and 1965, respectively. In 1969, he received his PhD in physical chemistry at the University of Utah under Professor Henry Eyring.[1]
Kim was considered a pioneer in the field of drug delivery. He was the founder of the International Symposium on Recent Advances in Drug Delivery, which is held biennially in Salt Lake City, Utah.
He was an elected member of the United States National Academies' Institute of Medicine (1999) and the National Academy of Engineering (2003). He was a Fellow in the American Association of Pharmaceutical Scientists, Biomaterials Society and American Institute for Medical and Biological Engineering.
Kim trained more than 100 scientists from 13 countries, had 25 patents and more than 550 publications.[1] In addition to his contributions to academia, Dr. Kim was a successful entrepreneur. He was the founder of Expression Genetics, Inc., MacroMed, Inc. (Acquired by Protherics, Plc) and a co-founder of TheraTech, Inc. (Acquired by Watson Pharmaceuticals).
A naturalized U.S. citizen, Dr. Kim was married and had two children.
He was awarded the Outstanding Paper in the Journal of Controlled Release three times, in 1989, 1991, and 1998.